FF

FVR – Finnish Vaccine Research at World Vaccine Congress Europe 2026

Oct 19–21, 2026 Amsterdam, Netherlands ~2k attendees Website

FVR – Finnish Vaccine Research takes part in 1 session at World Vaccine Congress Europe 2026 in Amsterdam, and exhibits at Booth 238. Its program centres on whether a shingles vaccine can help protect against dementia. It describes FinDementia, a trial run in routine care after approval that is designed to show whether the recombinant shingles vaccine lowers dementia risk.

OrganizationWorld Vaccine Congress Europe 2026 Attendance
FF
FVR – Finnish Vaccine Research
CRO, CDMO & labs
Finnish organization running vaccine clinical trials, including large pragmatic phase 4 studies.
Booth
Exhibiting at Booth 238
Talk
Wed Oct 21
10:30

Explore the full World Vaccine Congress Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Amsterdam. Leave your work email and we’ll be in touch.

Privacy

Download the full World Vaccine Congress Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from FVR – Finnish Vaccine Research

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by Terrapinn or the World Vaccine Congress. Submit a correction